Clinical trial
Microbiota as Potential Target for Innovative Preventive and Therapeutic Strategies for Food Allergy
NCT04750980 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiota as Potential Target for Innovative Preventive and Therapeutic Strategies for Food Allergy
- Lead sponsor
- Federico II University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2017
- Completion date
- January 30, 2021
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergy